chlorambucil and sdx 308

chlorambucil has been researched along with sdx 308 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aleskog, A; Chao, Q; Elliott, G; Larsson, R; Leoni, L; Lindhagen, E; Nissle, S1

Other Studies

1 other study(ies) available for chlorambucil and sdx 308

ArticleYear
R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
    Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:4

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chlorambucil; Doxorubicin; Drug Synergism; Etodolac; Female; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Middle Aged; Vincristine

2007